To explore the clinical significance of C17orf91 in ovarian cancer development, we first determined the differential C17orf91 expression between serous ovarian cancer tissues and normal ovarian surface epithelium(OSE) with resort to the GEO datasets. The gene discussed is MIR22HG; the disease is ovarian serous adenocarcinoma.